Email Alert | RSS    帮助

中国防痨杂志 ›› 2011, Vol. 33 ›› Issue (2): 91-94.

• 论著 • 上一篇    下一篇

三药和二药固定剂量复合剂需求测算方法的初步研究

徐汉成 陈诚 刘剑君 何广学   

  1. 中国疾病预防控制中心结核病预防控制中心 北京 102206
  • 收稿日期:2010-06-21 出版日期:2011-02-20 发布日期:2012-01-19

Research on the method of need for Fixed-dose combination drugs

Xu Hancheng,Chen Cheng,Liu Jia   

  1. National centre for tuberculosis prevention and control, China CDC, Beijing 102206, China
  • Received:2010-06-21 Online:2011-02-20 Published:2012-01-19
  • Contact: He Guangxue E-mail:heguangxue@chinatb.org

摘要: 目的 通过探讨结核病防治中固定剂量复合制剂需求测算方法 ,为各地进行药品测算提供参考依据,并为其他疾病进行药品需求测算提供借鉴。 方法 根据世界卫生组织推荐的固定剂量复合制剂的测算原理,获得符合我国特点的计算公式;通过对484例初治涂阳病人测量体质量,并且治疗随访获得2个月末未阴转率以及不良反应停药率以获得需求测算的参数。 结果三药复合制剂测算量:X×(A30-39×180+A30-39×R×90+A40-49×240+A40-49×R×120+A50×300+A50×R×150)×1.25;链霉素累计测算量:X×(22.5+11.25×R)×1.25。二药复合制剂累计测算量:X×(A30-39×180+A30-39×180+A50×240)×1.25。需要准备的单一制剂的人份数:X×B×1.25。X:某地区药品供应年新涂阳肺结核病人数,R:2个月末未阴转率,A30-39:30~39 kg 病人比例,A40-49:40~49-kg病人比例,A50:大于等于50 kg病人比例。需求测算的参数:体质量构成比为南方省份30~39 kg体质量组为5.88%(2.89%,8.87%),40~49 kg为40.34%(34.1%,46.6%),大于等于50 kg为53.78%(47.5%,60.1%);北方省份30~39 kg体质量组为3.7%(1.3%,6.0%),40~49 kg为21.6%(16.5%,26.8%),大于等于50 kg为74.7%(69.3%,80.1%)。2个月末未阴转率为5.5%(3.5%,7.5%)。不良反应停药率为2.7%(1.3%,4.1%)。 结论 该固定剂量复合制剂的计算原理和计算方法 ,能够为国家进行药品测算提供参考,并且可以为其他疾病的药品需求测算所借鉴。各地在开展药品测算时,应当开展小范围的预试验,以判断文中的参数是否符合本地情况。

关键词: 结核, 肺/药物疗法, 抗结核药, 固定剂量复合制剂, 算法

Abstract: Objective Research on the calculation formula of need for Fixed-dose combination drugs (FDCS) in NTP and estimative parameter, which will be shared by drug management systems of other diseases.  Methods Based on the calculation method of FDCS’s need, recommended by WHO, and the local FDCS’s characteristic, and the experience on drug supplying in china, obtain the calculation formula of need for Fixed-dose combination drugs (FDCS); the parameter for need calculation was obtained from 484 new smear positive cased by measure their weight and non-negative conversion rate at the end of second month and drug refuse rate.  Results Calculation formula: HRZ: X×(A30-39×180+A30-39×R×90+A 40-49×240+A40-49×R×120+A50×300+A50×R×150)×1.25.streptomycin: X×(22.5+11.25×R)×1.25.HR X×(A30-39×180+A 40-49×180+A50×240)×1.25. the loose drug:X×B×1.25.; parameter: south provinces:the proportion of 30~39 kg is 5.88%(2.89%,8.87%), the proportion of 40~49 kg is 40.34%(34.10%,46.57%), the proportion of more than 50 kg patient  kg is 53.78%(47.45%,60.12%).North provinces the proportion of 30~39 kg is 3.67%(1.32%,6.03%), the proportion of 40~49 kg is 21.63%(16.48%,26.79%), the proportion of more than 50 kg patient is 74.69%(69.25%,80.14%). non-negative conversion rate at the end of second month is 5.47%(3.46%,7.47%). drug refuse rate is 2.69%(1.25%,4.13%). Conclusion The calculative principle and formula has special reference to estimating the drug need in NTP, and be shared with other drug’s supply system.

Key words: tuberculosis,pulmonary/drug therapy, antitubercular agents, fixed-dose combination drugs, algorithms